JP3024845B2 - Method for producing immobilized lipase - Google Patents
Method for producing immobilized lipaseInfo
- Publication number
- JP3024845B2 JP3024845B2 JP03342866A JP34286691A JP3024845B2 JP 3024845 B2 JP3024845 B2 JP 3024845B2 JP 03342866 A JP03342866 A JP 03342866A JP 34286691 A JP34286691 A JP 34286691A JP 3024845 B2 JP3024845 B2 JP 3024845B2
- Authority
- JP
- Japan
- Prior art keywords
- activity
- lipase
- meq
- acid
- immobilized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は高活性な固定化リパーゼ
の製造方法に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing highly active immobilized lipase .
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】油脂の
改質、分解、エステル合成に利用される固定化リパーゼ
等の固定化酵素を製造する方法としては、酵素の活性発
現剤の存在下で、酵素を不溶性担体に固定化することに
よって高活性な固定化酵素を得る方法等がある。活性発
現剤としては、脂肪酸、脂肪酸誘導体、リン脂質、アル
コール類等の脂肪族化合物、ショ糖脂肪酸エステル等の
界面活性剤が検討されてきた(特開昭62−134090号、特
開昭63−214184号、特開平3−49684 号等)。しかしな
がら、これらの方法で固定化酵素を製造すると高活性化
は可能であるが、その再現性に問題があった。2. Description of the Related Art As a method for producing an immobilized enzyme such as an immobilized lipase used for reforming, decomposing, or synthesizing an oil or fat, a method for producing an immobilized enzyme in the presence of an enzyme activity-expressing agent is used. And a method of obtaining a highly active immobilized enzyme by immobilizing the enzyme on an insoluble carrier. Fatty acids, fatty acid derivatives, phospholipids, aliphatic compounds such as alcohols, and surfactants such as sucrose fatty acid esters have been studied as the activity-expressing agents (JP-A-62-134090, JP-A-63-134090). 214184, JP-A-3-49684, etc.). However, when an immobilized enzyme is produced by these methods, high activation is possible, but there is a problem in its reproducibility.
【0003】[0003]
【課題を解決するための手段】本発明者らは、上記課題
を解決するために、活性発現剤を用いる固定化リパーゼ
の製造方法を検討した結果、活性発現剤の自動酸化と、
固定化リパーゼの活性に高い相関があることを見出し
た。即ち活性発現剤が酸化されている場合、もしくは固
定化リパーゼの製造工程において酸化された場合、高い
活性を持つ固定化リパーゼの製造は困難になることを見
出し、本発明を完成するに到った。即ち、本発明は、脂
肪酸、脂肪酸誘導体、アルコール類、カルボニル化合物
類、エーテル類、ハロゲン化アルキル類、リン脂質及び
界面活性剤からなる群から選ばれた1種又は2種以上の
油溶性化合物からなる活性発現剤の存在下に固定化リパ
ーゼを製造する方法において、活性発現剤として過酸化
物価0〜2 meq/kg、好ましくは0〜1 meq/kgのもの
を用いることを特徴とする固定化リパーゼの製造方法を
提供するものである。Means for Solving the Problems In order to solve the above problems, the present inventors studied a method for producing an immobilized lipase using an activity developing agent. ,
It was found that the activity of immobilized lipase was highly correlated. That is, when the active developer is oxidized, or if oxidized in the production process of the immobilized lipase preparation of immobilized lipase with high activity found that difficulty, and have completed the present invention . That is, the present invention is, fat
Fatty acids, fatty acid derivatives, alcohols, carbonyl compounds
, Ethers, alkyl halides, phospholipids and
One or more selected from the group consisting of surfactants
Immobilized lipa in the presence of an oil-soluble compound
The present invention provides a method for producing immobilized lipase , which comprises using a peroxide having a peroxide value of 0 to 2 meq / kg, preferably 0 to 1 meq / kg, as an activity developing agent. is there.
【0004】活性発現剤の酸化の程度を測定する方法と
しては、過酸化物価の測定が一般的であり、過酸化物価
が2 meq/kg以下のもの(0〜2 meq/kgのもの)は、
酸化を受けていない活性発現剤といえる。本発明に用い
られる過酸化物価2 meq/kg以下(0〜2 meq/kg)の
酸化されていない活性発現剤は、一般的な精製法、即
ち、吸着剤処理、蒸留等で得ることができる。その保存
には不活性ガス雰囲気とするなど、酸素との接触を避け
たり、低温保存等の管理が必要となる。また抗酸化剤の
添加も効果がある。As a method for measuring the degree of oxidation of an activity developing agent, a peroxide value is generally measured, and those having a peroxide value of 2 meq / kg or less (0 to 2 meq / kg) are used. ,
It can be said that the agent has not been oxidized. The non-oxidized activity developing agent having a peroxide value of 2 meq / kg or less (0 to 2 meq / kg) used in the present invention can be obtained by a general purification method, that is, treatment with an adsorbent, distillation or the like. . For its storage, it is necessary to avoid contact with oxygen, such as in an inert gas atmosphere, and to manage such as low-temperature storage. The addition of an antioxidant is also effective.
【0005】また、本発明の方法において、固定化リパ
ーゼの製造中に活性発現剤の酸化を抑制することも重要
であり、そのためには固定化リパーゼの製造を低温で行
う方法や、実質的に酸素の存在しない系で行う方法、活
性発現剤に抗酸化剤を添加する方法を用いることもでき
る。ここで低温とは室温以下を示し、また実質的に酸素
の存在しない系とは、不活性ガス雰囲気や減圧の状態を
いい、酸素分圧が10 Torr 以下をいう。[0005] In the method of the present invention, the immobilized lipa
And it is also important to prevent the oxidation of the active developing agent during manufacture of over zero, a method to manufacture the immobilized lipase Therefore a method of performing at a low temperature, in a substantially oxygen existent systems, active developer Can be used. Here, "low temperature" means room temperature or lower, and "system substantially free of oxygen" means an inert gas atmosphere or a reduced pressure state, and means a partial pressure of oxygen of 10 Torr or less.
【0006】活性発現剤の存在下に固定化リパーゼを製
造する方法としては、リパーゼと活性発現剤を接触させ
たのち担体にリパーゼを固定化する方法、活性発現剤を
予め担体に吸着させたのちリパーゼを固定化する方法、
リパーゼを担体に固定化したのち活性発現剤を添加する
方法等があるが、本発明においてはいずれの方法も用い
ることができる。また活性発現剤とリパーゼとの接触、
担体への活性発現剤の吸着、リパーゼ固定化担体への活
性発現剤の添加の方法には特に限定はなく、無溶剤、水
あるいは有機溶剤の溶液、分散液の状態などを用いるこ
とができる。 As a method for producing an immobilized lipase in the presence of an active developer, a method for immobilizing lipase on a carrier after contacting the lipase and active developing agent was adsorbed in advance carrier activity enhancer How to immobilize lipase afterwards,
There is a method of immobilizing lipase on a carrier and then adding an activity-expressing agent. In the present invention, any method can be used. Also, contact between the activity-expressing agent and lipase ,
Adsorption of the active developing agent to the carrier, no particular limitation is imposed on the method of addition of the active developing agent to lipase immobilization carrier, solvent-free, the solution of water or an organic solvent, Ru can be used as the state of dispersion .
【0007】本発明で用いられる活性発現剤としては、
脂肪酸、脂肪酸誘導体、アルコール類、カルボニル化合
物類、エーテル類、ハロゲン化アルキル類、リン脂質及
び界面活性剤からなる群から選ばれた1種又は2種以上
の油溶性化合物等が挙げられる。本発明に用いられる脂
肪酸としては、炭素数2〜36のものが好ましく、更に好
ましくは8〜18のものであり、例えばカプリン酸、ラウ
リン酸、ミリスチン酸等の直鎖飽和脂肪酸、オレイン
酸、リノール酸等の不飽和脂肪酸、リシノール酸等のヒ
ドロキシ脂肪酸、もしくはイソステアリン酸等の分岐状
の脂肪酸が挙げられる。また脂肪酸誘導体としては、炭
素数2〜36好ましくは8〜18の脂肪酸と水酸基を有する
化合物とのエステルが挙げられ、1価アルコールエステ
ル、多価アルコールエステル、あるいはこれらのエステ
ルにさらにエチレンオキシドを付加した誘導体等が例示
される。1価アルコールエステルとしては、メチルエス
テル、エチルエステル等が、多価アルコールエステルと
しては、モノグリセリド、ジグリセリド、およびそれら
の誘導体、あるいはプロピレングリコール、ポリグリセ
リン等の多価アルコールの脂肪酸エステル等が挙げられ
る。[0007] The activity developing agent used in the present invention includes:
One or two or more oil-soluble compounds selected from the group consisting of fatty acids, fatty acid derivatives, alcohols, carbonyl compounds, ethers, alkyl halides, phospholipids and surfactants. The fatty acid used in the present invention is preferably one having 2 to 36 carbon atoms, more preferably 8 to 18 carbon atoms, for example, linear saturated fatty acids such as capric acid, lauric acid, myristic acid, oleic acid, linoleic acid and the like. Examples include unsaturated fatty acids such as acids, hydroxy fatty acids such as ricinoleic acid, and branched fatty acids such as isostearic acid. Examples of the fatty acid derivative include an ester of a fatty acid having 2 to 36 carbon atoms, preferably 8 to 18 carbon atoms, and a compound having a hydroxyl group. A monohydric alcohol ester, a polyhydric alcohol ester, or ethylene oxide is further added to these esters. Derivatives and the like are exemplified. Monohydric alcohol esters include methyl esters and ethyl esters, and polyhydric alcohol esters include monoglycerides, diglycerides, and derivatives thereof, and fatty acid esters of polyhydric alcohols such as propylene glycol and polyglycerin.
【0008】本発明に用いられるアルコール類として
は、炭素数4〜36、好ましくは8〜24の直鎖もしくは分
岐の脂肪族1価アルコール、例としてはオクチルアルコ
ール、ラウリルアルコール等の飽和アルコール、オレイ
ルアルコール等の不飽和アルコール、もしくは5−デカ
ノール、イソステアリルアルコール等の分岐状のもので
もよい。さらにヘキサメチレングリコール等の2価アル
コールや多価アルコールも有効である。このほかに、ア
ルキル置換フェノール等のフェノール化合物や、コレス
テロール、スチグマステロール、ブラシカステロール、
カンベステロール等のステロール類が挙げられる。又、
フィトール、ゲラニオール、ファルネソール、リナロー
ル等のテルペンアルコール類、レチノール、トコフェロ
ール等の脂溶性ビタミン類も有効である。本発明に用い
られるカルボニル化合物類の例としては、2,4 −デカジ
エナール、デカナール、ヘキサデカナール等の脂肪族ア
ルデヒド類、レチナール等のテルペン系アルデヒド類、
2−オクタノン、2−デカノン、オクチルデシルケトン
等の脂肪族ケトン類等が挙げられる。本発明に用いられ
るエーテル類の例としては、ジオクチルエーテル等の長
鎖のエーテル類、チミルアルコール、バチルアルコール
等のグリセリルエーテル類、またはグリシジルエーテル
等のグリセリド類似化合物、トリエチレングリコールモ
ノメチルエーテル、ポリエチレングリコールモノメチル
エーテル等のポリオキシ化合物、前記アルコールのトリ
メチルシリルエーテル誘導体、ポリメチルシロキサン等
のシリコン化合物等が挙げられる。本発明に用いられる
ハロゲン化アルキル類の例としては、オレイルクロライ
ド、オクチルクロライド、オクチルブロマイドのような
長鎖アルキルハライド等が挙げられる。The alcohols used in the present invention include linear or branched aliphatic monohydric alcohols having 4 to 36 carbon atoms, preferably 8 to 24 carbon atoms, for example, saturated alcohols such as octyl alcohol and lauryl alcohol, and oleyl. It may be an unsaturated alcohol such as alcohol, or a branched alcohol such as 5-decanol or isostearyl alcohol. Further, dihydric alcohols such as hexamethylene glycol and polyhydric alcohols are also effective. In addition, phenol compounds such as alkyl-substituted phenols, cholesterol, stigmasterol, brassicasterol,
Sterols such as cambesterol are exemplified. or,
Terpene alcohols such as phytol, geraniol, farnesol and linalool, and fat-soluble vitamins such as retinol and tocopherol are also effective. Examples of carbonyl compounds used in the present invention include 2,4-decadienal, decanal, aliphatic aldehydes such as hexadecanal, terpene aldehydes such as retinal,
Examples thereof include aliphatic ketones such as 2-octanone, 2-decanone and octyldecyl ketone. Examples of the ethers used in the present invention include long-chain ethers such as dioctyl ether, glyceryl ethers such as thymyl alcohol and batyl alcohol, or glyceride-like compounds such as glycidyl ether, triethylene glycol monomethyl ether, and polyethylene. Examples thereof include polyoxy compounds such as glycol monomethyl ether, trimethylsilyl ether derivatives of the alcohol, and silicon compounds such as polymethylsiloxane. Examples of the alkyl halides used in the present invention include long-chain alkyl halides such as oleyl chloride, octyl chloride, and octyl bromide.
【0009】本発明に用いられるリン脂質の例として
は、市販大豆レシチン、卵黄レシチン等の粗製およびま
たは精製混合レシチン等が挙げられ、またこれらを分画
して得たホスファチジルコリン、ホスファチジルセリ
ン、ホスファチジルエタノールアミン、ホスファチジル
イノシトール、ホスファチジン酸、カルジオリピン等を
単独または混合して用いてもよい。また各種合成法によ
り得た合成リン脂質およびこれらの誘導体を用いること
もできる。本発明に用いられる界面活性剤としては、シ
ョ糖脂肪酸エステル、ソルビタン脂肪酸エステル等が挙
げられる。Examples of the phospholipid used in the present invention include crude and / or purified mixed lecithin such as commercially available soybean lecithin and egg yolk lecithin, and phosphatidylcholine, phosphatidylserine, phosphatidylethanol obtained by fractionating these. Amine, phosphatidylinositol, phosphatidic acid, cardiolipin and the like may be used alone or as a mixture. Synthetic phospholipids obtained by various synthetic methods and derivatives thereof can also be used. Examples of the surfactant used in the present invention include sucrose fatty acid esters and sorbitan fatty acid esters.
【0010】本発明に用いられる抗酸化剤としては、ト
コフェロール、没食子酸、没食子酸誘導体、フラボノイ
ド類、ポリフェノール類、セサモール類、クエン酸、ク
エン酸誘導体、ジブチルヒドロキシトルエン、ブチルヒ
ドロキシアニソール、ノルジヒドログアレチック酸等が
挙げられる。The antioxidants used in the present invention include tocopherol, gallic acid, gallic acid derivatives, flavonoids, polyphenols, sesamoles, citric acid, citric acid derivatives, dibutylhydroxytoluene, butylhydroxyanisole, nordihydrog Alletic acid and the like.
【0011】本発明に用いられる担体としては、水およ
びアルコール、各種有機溶剤、油脂類に不溶性の担体な
ら何れでも良く、セライト、ケイソウ土、カオリナイ
ト、モレキュラーシーブ、多孔質ガラス、活性炭、炭酸
カルシウム、セラミックス等の無機担体、およびセルロ
ースパウダー、ポリビニルアルコール、キトサン、イオ
ン交換樹脂、吸着樹脂等の有機高分子の様なリパーゼ活
性に影響を与えず、操作上から物理的・化学的に安定な
ものであれば何れも使用できる。また担体の形状として
は、粉末状、顆粒状、繊維状、スポンジ状等種々ある
が、そのいずれでも使用できる。特に工程操作上の面か
らは400〜1000μm の粒径を有し、細孔径100〜1500Åの
多孔性の担体を用いるのが好適である。The carrier used in the present invention may be any carrier which is insoluble in water and alcohol, various organic solvents, fats and oils, and may be celite, diatomaceous earth, kaolinite, molecular sieve, porous glass, activated carbon, calcium carbonate. Inorganic carriers such as ceramics, and lipase activities such as organic polymers such as cellulose powder, polyvinyl alcohol, chitosan, ion-exchange resins, and adsorption resins, and are physically and chemically stable from operation. Any can be used. The carrier may be in various forms such as powder, granule, fiber, sponge, etc., and any of them can be used. In particular, from the viewpoint of the process operation, it is preferable to use a porous carrier having a particle size of 400 to 1000 μm and a pore size of 100 to 1500 °.
【0012】[0012]
【実施例】以下、実施例により、本発明を更に詳細に説
明するが、本発明はこれらの実施例に限定されるもので
はない。The present invention will be described in more detail with reference to the following examples, but the present invention is not limited to these examples.
【0013】実施例1 市販の弱アニオン交換樹脂{フェノールホルムアルデヒ
ド系樹脂、商品名:デュオライト(Duolite) A−568 、
デュオライト・インターナショナル社製}300gを0.1
N NaOH 3000mlに加え、水洗後、pH5、500 mM,50mMの
酢酸緩衝液でpHの平衡化を行い、濾別、減圧乾燥した。
この樹脂200 gに過酸化物価0.14 meq/kgのオレイン酸
(東京化成工業株式会社製)の10%エタノール溶液2リ
ットルを加え、20℃で30分間攪拌したのち、濾別、室温
減圧でエタノールを留去した。この樹脂150 gに市販の
リパーゼ{リゾプス・ジャポニカス起源のリパーゼ製
剤、商品名:リリパーゼA−10、ナガセ生化学工業社
製}を50mMのpH5、酢酸緩衝液に10%予め溶解させたリ
パーゼ溶液を1500ml加え、2時間攪拌し、固定化を行っ
た。次に、pH5、50mM酢酸緩衝液で1時間洗浄後、樹脂
を濾別し水分5%以下になるよう常温にて減圧乾燥し
た。濾液中のリパーゼ活性より求めた活性収率は92%と
なり、加えたリパーゼのほとんどが固定化された。Example 1 Commercially available weak anion exchange resin {phenol formaldehyde resin, trade name: Duolite A-568,
Duolight International Co., Ltd. ¥ 300g 0.1
After adding 3000 ml of N NaOH and washing with water, the pH was equilibrated with 500 mM, 50 mM acetate buffer at pH 5, followed by filtration and drying under reduced pressure.
To 200 g of this resin was added 2 liters of a 10% ethanol solution of oleic acid (manufactured by Tokyo Chemical Industry Co., Ltd.) having a peroxide value of 0.14 meq / kg, and the mixture was stirred at 20 ° C. for 30 minutes. Distilled off. A lipase solution in which a commercially available lipase (lipase preparation derived from Rhizopus japonicas, trade name: lipase A-10, manufactured by Nagase Seikagaku Corporation) was previously dissolved in 150 g of this resin in 50 mM of pH 5 and acetate buffer at 10%. Was added and the mixture was stirred for 2 hours to perform immobilization. Next, after washing with a 50 mM acetate buffer solution having a pH of 5 for 1 hour, the resin was separated by filtration and dried under reduced pressure at normal temperature so that the water content was 5% or less. The activity yield determined from the lipase activity in the filtrate was 92%, and most of the added lipase was immobilized.
【0014】得られた固定化リパーゼの活性を以下の方
法で測定した。流通管型の連続反応装置を用いてエステ
ル交換反応を行った。上記で得られた固定化酵素を酵素
塔に38g充填し、パーム油中融点部(ヨウ素価32.5、ジ
グリセリド含量4.6 %)1重量部に対して1.5 重量部の
割合で市販のステアリン酸{商品名:ルナックS−90、
ステアリン酸純度93%、花王株式会社製}を混合溶解し
た原料を、水分含量を0.10〜0.11%に調整した後、酵素
塔に通液させた(70℃)。反応物のGLCによるトリグ
リセリド組成、ステアリン酸取り込み率から反応速度定
数(Kst) を求めた。酵素の活性により酵素塔内の滞留
時間を0.23〜1.3時間の範囲で流量を操作しエステル交
換活性測定を行った。表1に反応速度定数を示した。[0014] The activity of the obtained immobilized lipase was measured by the following method. The transesterification reaction was performed using a flow tube type continuous reaction apparatus. 38 g of the immobilized enzyme obtained above was packed in an enzyme tower, and commercially available stearic acid was used in a ratio of 1.5 parts by weight to 1 part by weight of palm oil melting point (iodine value: 32.5, diglyceride content: 4.6%). : Lunac S-90,
The raw material obtained by mixing and dissolving stearic acid with a purity of 93% and manufactured by Kao Corporation was adjusted to a water content of 0.10 to 0.11%, and then passed through an enzyme tower (70 ° C). The reaction rate constant ( Kst ) was determined from the triglyceride composition of the reaction product by GLC and the stearic acid uptake rate. Depending on the activity of the enzyme, the transesterification activity was measured by controlling the flow rate within the range of 0.23 to 1.3 hours for the residence time in the enzyme tower. Table 1 shows the reaction rate constants.
【0015】比較例1 実施例1の過酸化物価0.14 meq/kgのオレイン酸の代わ
りに、過酸化物価6.2meq/kgのオレイン酸を用いる以
外、実施例1と同様に固定化酵素を製造した。濾液中の
リパーゼ活性から求めた活性収率は93%であった。また
実施例1と同様にエステル交換活性を測定し、表1に反
応速度定数を示した。Comparative Example 1 An immobilized enzyme was produced in the same manner as in Example 1 except that oleic acid having a peroxide value of 6.2 meq / kg was used instead of oleic acid having a peroxide value of 0.14 meq / kg. . The activity yield determined from the lipase activity in the filtrate was 93%. The transesterification activity was measured in the same manner as in Example 1. Table 1 shows the reaction rate constants.
【0016】実施例2 実施例1の過酸化物価0.14 meq/kgのオレイン酸の代わ
りに、過酸化物価0.04meq/kgのリシノール酸を用いる
以外、実施例1と同様に固定化酵素を製造した。濾液中
のリパーゼ活性から求めた活性収率は92%であった。ま
た実施例1と同様にエステル交換活性を測定し、表1に
反応速度定数を示した。Example 2 An immobilized enzyme was produced in the same manner as in Example 1 except that ricinoleic acid having a peroxide value of 0.04 meq / kg was used instead of oleic acid having a peroxide value of 0.14 meq / kg in Example 1. . The activity yield determined from the lipase activity in the filtrate was 92%. The transesterification activity was measured in the same manner as in Example 1. Table 1 shows the reaction rate constants.
【0017】比較例2〜3 実施例1の過酸化物価0.14 meq/kgのオレイン酸の代わ
りに、過酸化物価5.3meq/kgもしくは15.2 meq/kgのリ
シノール酸を用いる以外、実施例1と同様に固定化酵素
を製造した。濾液中のリパーゼ活性から求めた活性収率
はいずれも91%であった。また実施例1と同様にエステ
ル交換活性を測定し、表1に反応速度定数を示した。Comparative Examples 2-3 The same as Example 1 except that oleic acid having a peroxide value of 0.14 meq / kg was replaced with ricinoleic acid having a peroxide value of 5.3 meq / kg or 15.2 meq / kg. The immobilized enzyme was produced. The activity yields determined from the lipase activities in the filtrate were all 91%. The transesterification activity was measured in the same manner as in Example 1. Table 1 shows the reaction rate constants.
【0018】[0018]
【表1】 [Table 1]
フロントページの続き (72)発明者 大木 康正 茨城県鹿島郡神栖町知手中央5−2−3 (72)発明者 野村 誠治 千葉県香取郡小見川町小見川1569−3 (56)参考文献 特開 昭64−2588(JP,A) 特開 平1−153091(JP,A) (58)調査した分野(Int.Cl.7,DB名) C12N 11/00 C12N 9/20 BIOSIS(DIALOG) CA(STN) WPIDS(STN)Continuation of the front page (72) Inventor Yasumasa Oki 5-2-3, Chute, Kamisu-cho, Kashima-gun, Ibaraki (72) Inventor Seiji Nomura 1569-3, Omigawa-cho, Omigawa-cho, Katori-gun, Chiba (56) References JP Akira 64-2588 (JP, A) JP-A-1-153309 (JP, A) (58) Fields investigated (Int. Cl. 7 , DB name) C12N 11/00 C12N 9/20 BIOSIS (DIALOG) CA (STN ) WPIDS (STN)
Claims (2)
カルボニル化合物類、エーテル類、ハロゲン化アルキル
類、リン脂質及び界面活性剤からなる群から選ばれた1
種又は2種以上の油溶性化合物からなる活性発現剤の存
在下に固定化リパーゼを製造する方法において、活性発
現剤として過酸化物価0〜2 meq/kgのものを用いるこ
とを特徴とする固定化リパーゼの製造方法。Claims: 1. Fatty acids, fatty acid derivatives, alcohols,
Carbonyl compounds, ethers, alkyl halides
1 selected from the group consisting of phospholipids, phospholipids and surfactants
A method for producing an immobilized lipase in the presence of an activity developing agent comprising one or more oil-soluble compounds, wherein an activity developing agent having a peroxide value of 0 to 2 meq / kg is used. For producing immobilized lipase .
/kgのものを用いる請求項1記載の製造方法。2. A peroxide value of 0 to 1 meq as an activity developing agent.
The process according to claim 1, wherein the use of those / kg.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP03342866A JP3024845B2 (en) | 1991-12-25 | 1991-12-25 | Method for producing immobilized lipase |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP03342866A JP3024845B2 (en) | 1991-12-25 | 1991-12-25 | Method for producing immobilized lipase |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05168480A JPH05168480A (en) | 1993-07-02 |
JP3024845B2 true JP3024845B2 (en) | 2000-03-27 |
Family
ID=18357107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP03342866A Expired - Lifetime JP3024845B2 (en) | 1991-12-25 | 1991-12-25 | Method for producing immobilized lipase |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3024845B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001074161A2 (en) | 2000-04-04 | 2001-10-11 | Abr, Llc | Improved pesticide microemulsions and dispersant/penetrant formulations |
-
1991
- 1991-12-25 JP JP03342866A patent/JP3024845B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH05168480A (en) | 1993-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5128251A (en) | Immobilized lipolytic enzyme for esterification and interesterification | |
Maerker et al. | Cholesterol oxides I. Isolation and determination of some cholesterol oxidation products | |
EP0399544B1 (en) | Process for the production of phosphatidic acid | |
JP3549598B2 (en) | Method for producing polyglycerin fatty acid ester | |
Juneja et al. | Increasing productivity by removing choline in conversion of phosphatidylcholine to phosphatidylserine by phospholipase D | |
JP3024845B2 (en) | Method for producing immobilized lipase | |
JP2789793B2 (en) | Preparation of immobilized lipase enzyme preparation | |
JPH01262795A (en) | Immobilized enzyme and production thereof | |
JP5586855B2 (en) | Method for producing monoacylglycerol-rich oil and fat | |
Şekeroğlu et al. | Production and characterisation of enzymatically produced lauric acid esters of fructose | |
EP1931794B1 (en) | Two-stage process for producing fatty acids | |
JPH0971594A (en) | Production of fatty acid ester of sugar or sugaralcohol | |
JP2778135B2 (en) | Preparation method of lipase-immobilized enzyme preparation | |
JPS63214184A (en) | Immobilized enzyme and production thereof | |
Ho et al. | Nonenzymatic hydrolysis of phosphatidylcholine prepared as liposomes and mixed micelles | |
JP3037349B2 (en) | Enzyme-immobilizing carrier and method for producing immobilized enzyme | |
JP2716909B2 (en) | New immobilized carrier for lipolytic enzymes | |
JPH0712310B2 (en) | Immobilization method of lipolytic enzyme | |
JPH0710232B2 (en) | Lipolytic enzyme and method for ester synthesis and exchange reaction using the enzyme | |
JP2015119648A (en) | Method of producing polyglycerol monofatty acid ester | |
JPH06505148A (en) | Enzymatic reverse hydrolysis of hydrophilic substrates - method for producing amphiphilic compounds | |
Stein et al. | Column chromatography of lipids | |
JPH0710231B2 (en) | Immobilized enzyme and ester synthesis method using immobilized enzyme | |
JPH04258291A (en) | Immobilized enzyme and its production | |
JP2001252090A (en) | Method for producing diglyceride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090121 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090121 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100121 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110121 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110121 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120121 Year of fee payment: 12 |
|
EXPY | Cancellation because of completion of term |